Home/Axonis Therapeutics/Corey Goodman, Ph.D.
CG

Corey Goodman, Ph.D.

Executive Chairman & Co-Founder

Axonis Therapeutics

Therapeutic Areas

Axonis Therapeutics Pipeline

DrugIndicationPhase
AXN-027Epilepsy, Pain, and other CNS pathologiesPhase 1